{
  "created_at": "Fri Feb 18 6:25:33 +0000 2022",
  "id_str": "1494547886335569921",
  "full_text": "The firm plans to send its containerised mRNA factories—which it calls Biontainers—to parts of the world which lack their own vaccine-manufacturing capabilities https://t.co/IeaXGz0e3K",
  "display_text_range": [
    0,
    184
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/IeaXGz0e3K",
        "expanded_url": "https://econ.st/3rZqupO",
        "display_url": "econ.st/3rZqupO",
        "indices": [
          161,
          184
        ]
      }
    ]
  },
  "user": {
    "name": "The Economist",
    "screen_name": "TheEconomist",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/879361767914262528/HdRauDM-_normal.jpg"
  },
  "retweet_count": 39,
  "favorite_count": 100,
  "possibly_sensitive": false,
  "original_created_at": "Fri Feb 18 05:42:38 +0000 2022",
  "localize": [
    {
      "locale": "ja",
      "full_text": "同社は、コンテナ化したmRNA工場（同社ではバイオコンテナと呼んでいる）を、ワクチン製造能力が不足している世界の各地に送ることを計画している。https://t.co/IeaXGz0e3K"
    },
    {
      "locale": "zh",
      "full_text": "该公司计划将其集装箱式mRNA工厂--它称之为Biontainers--送往世界上缺乏自己的疫苗制造能力的地区，https://t.co/IeaXGz0e3K。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "該公司計劃將其集裝箱式mRNA工廠--它稱之爲Biontainers--送往世界上缺乏自己的疫苗製造能力的地區，https://t.co/IeaXGz0e3K。"
    }
  ]
}